http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112019021364-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6f21813a626cecb8a6267793cb192d1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
filingDate 2018-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd65f0c62e9987975b8435eeff31887f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_115c05d944bf0995174bf945bb3188ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71f6752e3a2c5eae7f2d4f2eeb7b661f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_431e775ed8fc4c9f5e3f4725d1d2de63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fc1e28c7d05ea7c6f59fa66982dccbe
publicationDate 2020-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112019021364-A2
titleOfInvention stable formulation of anti-osmr antibody
abstract the present invention relates, among other things, to stable formulations comprising an oncostatin m (osmr) antireceptor antibody and having a ph ranging from approximately 6.0? 7.6, where less than approximately 5% of the anti-osmr antibody exists as a high molecular weight (hmw) species in the formulation.
priorityDate 2017-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5008
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105621
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100334678
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID611921
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID36606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453109387
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID319086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810777
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412227895
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID492274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22610776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425120271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167571
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450428660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410072000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID736338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2RQT2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1RFE6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93554
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID289747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673815
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408258812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID492274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10986146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414664254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410143067
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID36606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450428657

Total number of triples: 94.